Category

FON Featured News
Anthemis releases Embedded Finance, a white paper on the future of the economy Anthemis sees the future state of financial services as embedded, augmented and ubiquitous. Rather than finance being discrete, Anthemis believes it is becoming an intimate part of the products and services that drive our economies — an often invisible but critical societal...
Read More
How to Invest in Biotech Series – Phases, Stages, and Pitfalls By Marc Appel, CEO, Orange Grove Bio Emily Whitehead was 5 years old when she was diagnosed with acute lymphoblastic leukemia, a serious yet the most common type of childhood cancer. Her cancer was resistant to traditional treatments and her prognosis was poor. In...
Read More
BioXyTran, Inc. — Tissue Regeneration for Life Bioxytran Inc. (OTC: BIXT) is a late stage biotechnology company that is developing a first-in-class oxygen treatment platform for victims of brain stroke trauma. The company’s lead drug candidate, BXT-25, is getting ready to proceed to testing.  BXT-25 has many properties of an existing, well tested drug, called...
Read More
Orange Grove Bio: Filling the Gap in Preclinical Drug Development Future Orange Grove Bio is a preclinical drug development company focused on driving down the cost of drug development and taking advantage of the exceptional science developed at universities across the country. Preclinical biopharma today represents one of the best opportunities in life sciences today....
Read More
Selecting Therapies for Cancer Patients: Past, Present, and Future Clifford Reid, PhD We are in the middle of a revolution in DNA sequencing, which has ushered in the era of precision medicine in cancer. Unfortunately, the impact of precision medicine has been quite limited, reaching only about 15% of cancer patients, and benefitting only about...
Read More
An Interview with Kristin Bedard PhD, Chief Scientific Officer Kineta Immuno-Oncology. KINETA, INC. – Innovation in Cancer Care, New Drugs in High Need Areas (PART 2). Part 2 In two previous articles, our readers were introduced to the Kineta, Inc. CEO Shawn Iadonato and Kristin Bedard PhD, the Chief Scientific Officer at the company.  In...
Read More
An Interview with Kristin Bedard PhD, Chief Scientific Officer Kineta Immuno-Oncology. KINETA, INC. – Innovation in Cancer Care, Developing (and Investing in) New Drugs in High Need Areas. Part 1 In a previous article, our readers were introduced to your co-founder and Kineta, Inc. CEO Shawn Iadonato.  In that article we shared with our readers...
Read More
Winc: A Modern Winery Winc is a modern winery, where a direct connection to the consumer drives a portfolio of brands for the next generation of wine drinkers. The company has quickly scaled from start to over $200MM in revenue over the past seven years.  Winc will be Constellation Brands for the next generation of consumers. Winc...
Read More
Beyond Boundaries: Art Collecting in the Present By definition contemporary art refers to art that belongs to or is created in the present moment. Most of what is written and discussed on contemporary art is dedicated to the icons of the 20th Century: Picasso, Lichtenstein, Warhol as well as others who cross the boundaries such...
Read More
Presenting:  Family Office Networks‘  Luxury Lifestyle Magazine Holiday Issue Holiday Special Available to Select Luxury Advertisers Palm Beach, FL – (October 23, 2019) – Family Office Networks announced today the upcoming publication of the holiday issue of luxury lifestyle magazine FON Magazine. The full-color glossy magazine provides wealthy families with curated content on topics such as art, automobiles, boats,...
Read More
1 2

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases